Akari Therapeutics

NASDAQ: AKTX · Real-Time Price · USD
1.00
-0.01 (-0.98%)
At close: Aug 18, 2025, 3:58 PM
0.96
-4.00%
After-hours: Aug 18, 2025, 04:10 PM EDT

Akari Therapeutics Stock Forecast

Stock Price Forecast

The 1 analysts with 12-month price forecasts for AKTX stock have an median target of 5, with a low estimate of 5 and a high estimate of 5. The median target predicts an increase of 400.00% from the current stock price of 1.00.

Target Low Average Median High
Price 5 5 5 5
Change 400.00% 400.00% 400.00% 400.00%

Latest Analyst Insight Report

According to 1 stock analyst, the rating for Akari Therapeutics is "Buy". This means that the analyst believes this stock is likely to lead to higher returns than market as a whole.

Rating Jul 25
Strong Buy 0
Buy 1
Hold 0
Sell 0
Strong Sell 0
Total 1

Financial Forecast this Year

Revenue This Year
3.54M
from 0
Increased by n/a%
Revenue Next Year
9.58M
from 3.54M
Increased by 170.6%
EPS This Year
-0.45
from -160
Increased by 99.7%
EPS Next Year
-0.46
from -0.45
Increased by -2.2%